{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_doxorubicin",
          "name": "Doxorubicin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_temozolomide",
          "name": "Temozolomide"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_vincristine",
          "name": "Vincristine"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_irinotecan",
          "name": "Irinotecan"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_carboplatin",
          "name": "Carboplatin"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_cisplatin",
          "name": "Cisplatin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_bevacizumab",
          "name": "Bevacizumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_gemcitabine",
          "name": "Gemcitabine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_procarbazine",
          "name": "Procarbazine"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_target1",
          "type": "Target",
          "label": "Topoisomerase II",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target2",
          "type": "Target",
          "label": "DNA Alkylator",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target3",
          "type": "Target",
          "label": "Antimetabolite",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target4",
          "type": "Target",
          "label": "Microtubule Inhibitor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target5",
          "type": "Target",
          "label": "Vascular Endothelial Growth Factor (VEGF)",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway1",
          "type": "Pathway",
          "label": "Cell Cycle Regulation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway2",
          "type": "Pathway",
          "label": "Apoptosis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease",
          "type": "Disease",
          "label": "Familial Tumour Syndromes of the CNS",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_doxorubicin",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知靶点，有效性支持"
        },
        {
          "source": "drug_temozolomide",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "DNA 甲基化机制连接"
        },
        {
          "source": "drug_vincristine",
          "target": "n_target4",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "微管靶向药物的作用"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_target3",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "抗代谢药的作用机制"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与DNA损伤机制相关"
        },
        {
          "source": "drug_irinotecan",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "与topoisomerase II的关系"
        },
        {
          "source": "drug_etoposide",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "已知机制关联"
        },
        {
          "source": "drug_carboplatin",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "DNA交联机制"
        },
        {
          "source": "drug_cisplatin",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "DNA交联机制"
        },
        {
          "source": "drug_bevacizumab",
          "target": "n_target5",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "VEGF靶向治疗"
        },
        {
          "source": "n_target1",
          "target": "n_pathway1",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通路反应的一部分"
        },
        {
          "source": "n_target2",
          "target": "n_pathway2",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Apoptosis通路关联"
        },
        {
          "source": "n_target3",
          "target": "n_pathway1",
          "relation": "involved_in",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "抗代谢药物的通路有效性"
        },
        {
          "source": "n_target4",
          "target": "n_pathway2",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "微管靶向作用途径"
        },
        {
          "source": "n_pathway1",
          "target": "n_disease",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通路与疾病关联"
        },
        {
          "source": "n_pathway2",
          "target": "n_disease",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "重要的病理通路"
        },
        {
          "source": "drug_doxorubicin",
          "target": "H1",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_temozolomide",
          "target": "H2",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_vincristine",
          "target": "H3",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_methotrexate",
          "target": "H4",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "H5",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_irinotecan",
          "target": "H6",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_etoposide",
          "target": "H7",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_carboplatin",
          "target": "H8",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_cisplatin",
          "target": "H9",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_bevacizumab",
          "target": "H10",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_gemcitabine",
          "target": "H11",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        },
        {
          "source": "drug_procarbazine",
          "target": "H12",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "机制闭环支持"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种化疗药物通过不同机制影响中枢和外周神经系统的家族性肿瘤综合征",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "药物通过系统性应用能够达到相关组织与肿瘤细胞"
    ],
    "uncertainties": [
      "不同药物的长期效果及安全性需进一步研究确认"
    ],
    "next_focus_for_pi": [
      "对与靶向机制和疗效的临床证据进行综述"
    ]
  }
}